Comparative analysis of different commercial ELISA systems for the detection of anti-neutrophil cytoplasm antibodies in ANCA-associated vasculitides

Clinical and Experimental Rheumatology

Volumn 30, Issue SUPPL. 70, 2012, Pages

  Holle, Julia U ^a   Herrmann, Kristine ^a   Gross, Wolfgang L ^a   Csernok, Elena ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Anti neutrophil cytoplasm antibodies; ELISA; Granulomatosis with polyangiitis; Microscopic polyangiitis

Indexed keywords

MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANCA ASSOCIATED VASCULITIS; ANTIBODY DETECTION; ARTICLE; BLOOD ANALYSIS; CAPTURE MYELOBLASTIN NEUTROPHIL CYTOPLASMIC ANTIBODY ENZYME LINKED IMMUNOSORBENT ASSAY; CAPTURE MYELOPEROXIDASE NEUTROPHIL CYTOPLASMIC ANTIBODY ENZYME LINKED IMMUNOSORBENT ASSAY; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DILUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH SENSITIVITY MYELOBLASTIN NEUTROPHIL CYTOPLASMIC ANTIBODY ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH SENSITIVITY MYELOPEROXIDASE NEUTROPHIL CYTOPLASMIC ANTIBODY ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STANDARDIZATION;

ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GERMANY; HUMANS; MYELOBLASTIN; PEROXIDASE; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY;

EID: 84863768145     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. DE LEEUW K, BIJZET J, VEN DER GRAAF AM et al.: Patients with Wegener's granulomatosis: a long-term follow-up study. Clin Exp Rheumatol 2010; 28 (Suppl. 57): 18-23.
2. MARITSI D, CHAVASSE R, PILKINGTON CA et al.: Churg-Strauss syndrome in childhood: a rare form of systemic vasculitis posing a great diagnostic challenge. Clin Exp Rheumatol 2011; 29 (Suppl. 64): S135.
3. SAVIGE J, DIMECH W, FRITZLER M et al.: Addendum to the International Consensus Statement on testing and reporting of antineutrophil cytoplasmatic antibodies. Quality control guidelines, comments and recommendations for testing in other autoimmune diseases. Am J Clin Pathol 2003; 120: 312-4.
4. CSERNOK E, HOLLE J, HELLMICH B et al.: Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies against proteinase-3 in Wegener's granulomatosis: first results from a multicenter study. Rheumatology 2004; 43: 174-180.
5. HOLLE JU, CSERNOK E, FREDENHAGEN G et al.: Clinical evaluation of hsPR3-ANCA ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase
6. DAMOISEAUX J, DÄHNRICH C, ROSEMANN A et al.: A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential fo antineutrophil cytoplasmic antibody-associated vasculitis. Ann Rheum Dis 2009; 68: 228-33.
7. ROGGENBUCK D, BUETTNER T, HOFFMANN L et al.: High sensitivity detection of autoantibodies against proteinase 3 by a novel thirdgeneration enzyme-linked immunoabsorbent assay. Ann N Y Acad Sci 2009; 1173: 41-6.
8. TREVISIN M, NEESON P, SAVIGE J: The binding of proteinase 3 antineutrophil cytoplasmic antibodies (PR3-ANCA) varies on different ELISAs. J Clin Pathol 2004; 57: 303-8.
9. LEAVITT RY, FAUCI AS, BLOCH DA et al.: The American College of Rheumatology 1990 Criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 22: 1101-7.
10. MASI AT, HUNDER GG, LIE JT et al.: The American College of Rheumatology 1990 Criteria for the classification of Churg- Strauss syndrome (Allergic granulomatosis and angiitis). Arthritis Rheum 1990; 33: 1094-100.
11. HOLLE JU, GROSS WL, HOLL-ULRICH K et al.: Prospective longterm follow-up of localized Wegener's granulomatosis: Does it occur as persistent disease stage? Ann Rheum Dis 2012; 69: 907-14.
12. HOLLE JU, WU QJ, MOOSIG F et al.: Membrane proteinase 3 (mPR3) expression on neutrophils is not increased in localized Wegener's granulomatosis (WG) and Churg- Strauss syndrome (CSS). Clin Exp Rheumatol 2010; 28 (Suppl. 57): 46-50.
13. JENNETTE JC, FALK RJ, ANDRASSY K et al.: Nomenclature of systemic vasculitides. Proposal of an International Consensus Conference. Arthritis Rheum 1994; 37: 187-92.
14. FAGIN U, CSERNOK E, MÜLLER A et al.: Distinct proteinase 3-induced cytokine patterns in Wegener's granulomatosis, Churg-Strauss syndrome, and healthy controls. Clin Exp Rheumatol 2011; 29 (Suppl. 64): S57-62.
15. MUKHTYAR C, LEE R, BROWN D et al.: Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis 2009; 68: 1827-32.